JP Morgan Chase’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.3M | Sell |
457,639
-85,315
| -16% | -$4.5M | ﹤0.01% | 2056 |
|
|
2025
Q4 | $28.5M | Sell |
542,954
-50,462
| -9% | -$3.02M | ﹤0.01% | 1758 |
|
|
2025
Q3 | $38.5M | Buy |
593,416
+272,322
| +85% | +$15.6M | ﹤0.01% | 1583 |
|
|
2025
Q2 | $15.6M | Buy |
321,094
+25,107
| +8% | +$972K | ﹤0.01% | 2149 |
|
|
2025
Q1 | $10.1M | Buy |
295,987
+6,810
| +2% | +$289K | ﹤0.01% | 2539 |
|
|
2024
Q4 | $11.4M | Sell |
289,177
-65,065
| -18% | -$3.07M | ﹤0.01% | 2573 |
|
|
2024
Q3 | $16.6M | Buy |
354,242
+25,173
| +8% | +$1.28M | ﹤0.01% | 2152 |
|
|
2024
Q2 | $17.8M | Sell |
329,069
-63,681
| -16% | -$3.68M | ﹤0.01% | 1964 |
|
|
2024
Q1 | $26.8M | Sell |
392,750
-70,520
| -15% | -$5.05M | ﹤0.01% | 1694 |
|
|
2023
Q4 | $29M | Sell |
463,270
-57,159
| -11% | -$3.16M | ﹤0.01% | 1554 |
|
|
2023
Q3 | $23.6M | Sell |
520,429
-30,966
| -6% | -$1.6M | ﹤0.01% | 1556 |
|
|
2023
Q2 | $31M | Sell |
551,395
-31,269
| -5% | -$1.77M | ﹤0.01% | 1384 |
|
|
2023
Q1 | $26.4M | Sell |
582,664
-6,959
| -1% | -$338K | ﹤0.01% | 1469 |
|
|
2022
Q4 | $24M | Sell |
589,623
-23,267
| -4% | -$1.23M | ﹤0.01% | 1527 |
|
|
2022
Q3 | $40.1M | Sell |
612,890
-50,170
| -8% | -$3.64M | 0.01% | 1151 |
|
|
2022
Q2 | $40.3M | Buy |
663,060
+16,488
| +3% | +$969K | 0.01% | 1164 |
|
|
2022
Q1 | $40.6M | Sell |
646,572
-125,327
| -16% | -$7.87M | 0.01% | 1277 |
|
|
2021
Q4 | $58.5M | Buy |
771,899
+127,313
| +20% | +$11.1M | 0.01% | 1134 |
|
|
2021
Q3 | $72.2M | Buy |
644,586
+71,245
| +12% | +$8.95M | 0.01% | 1014 |
|
|
2021
Q2 | $92.8M | Buy |
573,341
+22,931
| +4% | +$2.79M | 0.01% | 936 |
|
|
2021
Q1 | $67.1M | Buy |
550,410
+98,750
| +22% | +$14.9M | 0.01% | 1042 |
|
|
2020
Q4 | $69.2M | Buy |
451,660
+44,845
| +11% | +$5.3M | 0.01% | 940 |
|
|
2020
Q3 | $34.6M | Buy |
406,815
+159,481
| +64% | +$14.1M | 0.01% | 1162 |
|
|
2020
Q2 | $18.2M | Buy |
247,334
+52,719
| +27% | +$3.08M | ﹤0.01% | 1429 |
|
|
2020
Q1 | $8.25M | Sell |
194,615
-44,014
| -18% | -$2.27M | ﹤0.01% | 1887 |
|
|
2019
Q4 | $14.5M | Buy |
238,629
+234,025
| +5,083% | +$12.8M | ﹤0.01% | 1814 |
|
|
2019
Q3 | $188K | Sell |
4,604
-126,933
| -96% | -$6.07M | ﹤0.01% | 4660 |
|
|
2019
Q2 | $5.97M | Buy |
131,537
+127,333
| +3,029% | +$5.09M | ﹤0.01% | 2495 |
|
|
2019
Q1 | $151K | Sell |
4,204
-47,553
| -92% | -$1.64M | ﹤0.01% | 4736 |
|
|
2018
Q4 | $1.48M | Sell |
51,757
-268,726
| -84% | -$9.34M | ﹤0.01% | 3493 |
|
|
2018
Q3 | $14.2M | Buy |
320,483
+267,672
| +507% | +$14M | ﹤0.01% | 1912 |
|
|
2018
Q2 | $3.1M | Buy |
+52,811
| New | +$3.01M | ﹤0.01% | 3067 |
|
|
2018
Q1 | – | Sell |
-107,444
| Closed | -$2.52M | – | 5422 |
|
|
2017
Q4 | $2.52M | Buy |
107,444
+76,787
| +250% | +$1.46M | ﹤0.01% | 3176 |
|
|
2017
Q3 | $536K | Buy |
+30,657
| New | +$556K | ﹤0.01% | 3804 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
